Title	Publication Date	Language	Citations
Trial Watch	2012/07/01	English	68
High sensitivity of cancer exome-based CD8 T cell neo-antigen identification	2014/05/01	English	68
BRAF inhibition improves tumor recognition by the immune system	2012/12/01	English	67
Trial Watch	2014/06/01	English	66
Characterization of an adaptive immune response in microsatellite-instable colorectal cancer	2014/06/01	English	65
The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration	2013/12/01	English	64
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy	2014/02/27	English	64
NK cell-released exosomes	2013/01/01	English	62
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines	2014/08/03	English	62
The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8+T cells into innate-like effector cells with antitumor activity	2013/11/01	English	61
Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo	2014/01/01	English	61
Why do human B cells secrete granzyme B? Insights into a novel B-cell differentiation pathway	2012/11/01	English	60
Trial Watch	2014/01/01	English	60
AttenuatedListeria monocytogenesreprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis	2014/05/01	English	60
Radiation and anti-PD-L1 antibody combinatorial therapy induces T cell-mediated depletion of myeloid-derived suppressor cells and tumor regression	2014/04/01	English	60
Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention	2014/04/01	English	59
Myeloid derived suppressor cells	2013/04/01	English	59
The anticancer effects of HDAC inhibitors require the immune system	2014/01/01	English	59
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients	2013/08/01	English	59
Chimeric antigen receptor T cells are vulnerable to immunosuppressive mechanisms present within the tumor microenvironment	2014/11/02	English	58
Trial watch: Dendritic cell-based anticancer therapy	2014/11/02	English	58
Functional differences between low- and high-affinity CD8+T cells in the tumor environment	2012/11/01	English	57
Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer	2012/01/01	English	57
PD-1 and BTLA and CD8+T-cell “exhaustion” in cancer	2012/08/01	English	57
Role of lymphocytes in liver cancer	2013/11/01	English	56
Quantitative T cell repertoire analysis by deep cDNA sequencing of T cell receptor α and β chains using next-generation sequencing (NGS)	2014/11/26	English	56
Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer	2013/03/01	English	56
Trial Watch	2012/05/01	English	56
Tumor-infiltrating B cells and T cells	2012/12/01	English	56
Instruction of myeloid cells by the tumor microenvironment: Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations	2012/10/01	English	56